— Know what they know.
Not Investment Advice

Financial News

Sentiment 46.2 5329 articles 2917 bullish 1267 bearish Full Index →
📰

NANOBIOTIX Statement Regarding Recent Media Speculation

PARIS and CAMBRIDGE, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering...
📰

Declaration de NANOBIOTIX concernant une recente rumeur mediatique

PARIS, FRANCE; CAMBRIDGE, Massachusetts, 25 mars 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société...
📰

NANOBIOTIX Statement Regarding Recent Media Speculation

PARIS and CAMBRIDGE, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage...
📰

Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year?

Here is how Astellas Pharma Inc. (ALPMY) and Cardinal Health (CAH) have performed compared to their sector so far this year.
📰

Is Astellas Pharma (ALPMY) Outperforming Other Medical Stocks This Year?

Here is how Astellas Pharma Inc. (ALPMY) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Is Novo Nordisk's Experimental Obesity Drug Outperforming Se

Is Novo Nordisk's Experimental Obesity Drug Outperforming Semaglutide?

The United Laboratories International Holdings Limited and Novo Nordisk A/S (NYSE:NVO) reported Wednesday topline data from a phase 2 trial in China...
Is Novo Nordisk's Experimental Obesity Drug Outperforming Se

Is Novo Nordisk's Experimental Obesity Drug Outperforming Semaglutide?

The United Laboratories International Holdings Limited and Novo Nordisk A/S (NYSE:NVO) reported Wednesday topline data from a phase 2 trial in China...
📰

Sarepta Therapeutics (SRPT) at a Crossroads: A 2026 Deep Dive into the Future of Genetic Medicine - FinancialContent

Sarepta Therapeutics (SRPT) at a Crossroads: A 2026 Deep Dive into the Future of Genetic Medicine  FinancialContent
Architect Financial Technologies Partners with MarketVector

Architect Financial Technologies Partners with MarketVector Indexes to Launch Interest Rate Perpetual Futures on AX

Partnership introduces the financial industry's first exchange-traded perpetual futures on interest rate benchmarks CHICAGO, March 25, 2026...
📰

Are Options Traders Betting on a Big Move in CONMED Stock?

Investors need to pay close attention to CNMD stock based on the movements in the options market lately.
📰

Nasus Pharma Ltd. reports FY results

📰

Gear Up for Phreesia (PHR) Q4 Earnings: Wall Street Estimates for Key Metrics

Beyond analysts' top-and-bottom-line estimates for Phreesia (PHR), evaluate projections for some of its key metrics to gain a better insight into how...
📰

SRx Health Solutions Hedges Decentralized Finance (DeFi) Portfolio with Investment in Gold and Reduces its Emerging Market Hedge

NORTH PALM BEACH, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies...
📰

SRx Health Solutions Hedges Decentralized Finance (DeFi) Portfolio with Investment in Gold and Reduces its Emerging Market Hedge

NORTH PALM BEACH, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") and EMJ Crypto...
📰

Absci (ABSI) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.Tuesday, March 24, 2026 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
📰

Spectral AI (MDAI) Q4 2025 Earnings Transcript

Image source: The Motley Fool.Tuesday, March 24, 2026 at 5 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
Formedics Partners with The Immunobuddies to Deliver Strateg

Formedics Partners with The Immunobuddies to Deliver Strategic Market Expansion

BASKING RIDGE, N.J., March 25, 2026 /PRNewswire/ -- Formedics, a leading healthcare media and physician engagement company, is strategically...
Mercanto Holdings Inc. Reports Q2 2026 Financial Results and

Mercanto Holdings Inc. Reports Q2 2026 Financial Results and Provides Commercial Update on Québec Product Launches

MONTRÉAL, March 25, 2026 /CNW/ - Mercanto Holdings Inc. (TSXV:MUSH) ("Mercanto" or the "Company") today reported its financial results for the second...
Investors Heavily Search AbbVie Inc. (ABBV): Here is What Yo

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know

Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It

Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the...
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts t

Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store.
📰

Recursion names Vicki Goodman as CMO

📰

Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains?

Assertio (ASRT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate...
📰

BeyondSpring Reports 2025 Year-End Financial Results

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"...
📰

BeyondSpring Reports 2025 Year-End Financial Results

Plinabulin (BeyondSpring's Lead Program):
📰

Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now

Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?

ZBH leans on knee growth, robotics innovation and steady markets, but debt levels and stiff competition complicate its near-term investment appeal.
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now

Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?

ZBH leans on knee growth, robotics innovation and steady markets, but debt levels and stiff competition complicate its near-term investment appeal.
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now

Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?

ZBH leans on knee growth, robotics innovation and steady markets, but debt levels and stiff competition complicate its near-term investment appeal.
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now

Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?

ZBH leans on knee growth, robotics innovation and steady markets, but debt levels and stiff competition complicate its near-term investment appeal.
CTA Construction Managers Awarded Contract to Build New Burl

CTA Construction Managers Awarded Contract to Build New Burlington Police Station

The new facility will replace the existing police station, which was originally constructed in the 1890s. BURLINGTON, Mass., March 25, 2026...
📰

ProMIS Neurosciences Announces Full Year 2025 Financial Results and Provides Corporate Highlights

PRECISE-AD Phase 1b trial fully enrolled. Completion of six-month assessments expected in Q2 2026 with blinded interim analysis anticipated early Q3...
📰

Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research

Company Joins AASM Foundation Corporate Recognition Program and Sponsors Junior Investigator Research Grant as IHL-42X Advances Toward Potential Oral...
Nota AI and SiMa.ai Sign Strategic Partnership for Physical

Nota AI and SiMa.ai Sign Strategic Partnership for Physical AI Technology Collaboration

"Combining AI Optimization with High Performance and Efficiency MLSoCs to Lead the Physical AI Market" Nota AI's AI Optimization Technology Meets...
📰

AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program

FDA provided constructive feedback on Company's analytical similarity strategy under the 351(k) biosimilar pathway  Company continues to execute...
📰

AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program

AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
📰

Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer

Salt Lake City, UT, March 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to...
📰

Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer

BRISBANE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA), a biotechnology company focused on developing and...
📰

Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer

BRISBANE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (NASDAQ:VERA), a biotechnology company focused on developing and...
📰

Picard Medical reports FY results

Earnings Scheduled For March 25, 2026

Earnings Scheduled For March 25, 2026

Companies Reporting Before The Bell • Chewy (NYSE:CHWY) is expected to report quarterly earnings at $0.20 per share on revenue of $3.26 billion. •...
Earnings Scheduled For March 25, 2026

Earnings Scheduled For March 25, 2026

Companies Reporting Before The Bell • Chewy (NYSE:CHWY) is expected to report quarterly earnings at $0.20 per share on revenue of $3.26 billion. •...
Earnings Scheduled For March 25, 2026

Earnings Scheduled For March 25, 2026

Companies Reporting Before The Bell • Chewy (NYSE:CHWY) is expected to report quarterly earnings at $0.20 per share on revenue of $3.26 billion. •...
Earnings Scheduled For March 25, 2026

Earnings Scheduled For March 25, 2026

Companies Reporting Before The Bell • Chewy (NYSE:CHWY) is expected to report quarterly earnings at $0.20 per share on revenue of $3.26 billion. •...
« Prev 1 2 3 4 5 15 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms